Methyl Benzoate

Methyl Benzoate

SCHEMBL27832129

COC(=O)c1ccccc1.c1cc2ccc1CO2

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.61
RAB9A P51151 6/20 0.46
MAPT P10636 4/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
CASP3 P42574 1/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46
CA1 P00915 4/20 0.45
CA2 P00918 4/20 0.45
SMN1; SMN2 Q16637 3/20 0.44
NPC1 O15118 3/20 0.44
ALDH1A1 P00352 3/20 0.44
PTPN1 P18031 1/20 0.44
HPGD P15428 1/20 0.44
AGTR1 P30556 1/20 0.44
SLC6A3 Q01959 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Benzoate SCHEMBL27650205 0.83 TSHR (0.56) TSHRRAB9AMAPTL3MBTL1CASP3
Acetophenone SCHEMBL27779041 0.81 SMN1; SMN2 (0.46) TSHRRAB9AMAPTL3MBTL1SMN1; SMN2
SCHEMBL10322890 0.80 NPSR1 (0.48) ALDH1A1PTPN1MEN1KMT2APOLB
Methyl Benzoate SCHEMBL28244665 0.79 TSHR (0.76) TSHRRAB9AMAPTL3MBTL1CASP3
Methyl Benzoate SCHEMBL29831725 0.78 TSHR (1.00) TSHRRAB9AMAPTL3MBTL1CASP3
Methyl Benzoate SCHEMBL28537345 0.78 TSHR (1.00) TSHRRAB9AMAPTL3MBTL1CASP3
Methyl Benzoate SCHEMBL28945661 0.78 TSHR (1.00) TSHRRAB9AMAPTL3MBTL1CASP3
Methyl Benzoate SCHEMBL1867855 0.78 TSHR (1.00) TSHRRAB9AMAPTL3MBTL1CASP3
Methyl Benzoate SCHEMBL1332323 0.78 TSHR (1.00) TSHRRAB9AMAPTL3MBTL1CASP3
Methyl Benzoate SCHEMBL29105567 0.78 TSHR (1.00) TSHRRAB9AMAPTL3MBTL1CASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102300860-B Pyrazine Compounds As Phosphodiesterase 10 Inhibitors AMGEN INC 2014-08-27 CN disclosed
CN-102300860-A Pyrazine compounds as phosphodiesterase 10 inhibitors 2011-12-28 CN disclosed
CN-102015712-A Heterocyclic compounds as adenosine receptor antagonist ADVINUS THERAPEUTICS PVT LTD 2011-04-13 CN disclosed